Your session is about to expire
← Back to Search
Negative Pressure Wound Therapy for Breast Reconstruction in Obese Patients
Study Summary
This trial studies the safety and how well negative pressure wound therapy works in healing the abdominal incision in obese patients undergoing free flap breast reconstruction surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent by myself.You have a BMI of 30 or higher.I am having a specific type of breast reconstruction using tissue from my abdomen.
- Group 1: Group II (NPWT)
- Group 2: Group I (wound care with a standard dressing)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the number of participants involved in this experiment?
"Affirmative. Clinicaltrials.gov records indicate that this experiment is actively enrolling patients since its posting on May 2nd, 2019 and last update on May 16th 2022. 80 individuals are necessary from a single medical centre for the study to be completed successfully."
Is there an open enrollment period for participation in this research project?
"Affirmative, the clinical trial is still recruiting. According to information available on clinicaltrials.gov, this study first went live on May 2nd 2019 and was recently updated on May 16th 2022. With one site in operation, 80 participants are necessary for completion of the trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger